Fumaric acid esters for psoriasis: patient perceptions of an unlicensed medication [Abstract]

Hodges, Nick, Anstey, Alex and Ingram, John R. ORCID: https://orcid.org/0000-0002-5257-1142 2012. Fumaric acid esters for psoriasis: patient perceptions of an unlicensed medication [Abstract]. Journal of the American Academy of Dermatology 66 (4) , AB193-AB193. 10.1016/j.jaad.2011.11.809

Full text not available from this repository.

Abstract

Fumaric acid esters (FAEs) are unlicensed for the treatment of psoriasis in the United Kingdom, and as a result there is less information available to patients. The British Association of Dermatologists (BAD) recently produced a patient information leaflet on FAEs. The objective of this evaluation study was to look at whether patients are getting enough information about the drug prior to commencing treatment, how they are getting their information, and whether they could be supported better.

Item Type:	Article
Date Type:	Publication
Status:	Published
Schools:	Medicine
Subjects:	R Medicine > RL Dermatology
Publisher:	Elsevier
Last Modified:	31 Oct 2022 10:28
URI:	https://orca.cardiff.ac.uk/id/eprint/85004

Actions (repository staff only)

Edit Item